★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★Open research. Global perspectives.
Medical Sciences OPEN ACCESS

The State Of The Prostacycline-Thromboxane System In Patients With Ischemic Heart Disease

Khattahanova Rabiya Yuldashevna,
Candidate Of Medical Sciences, Senior Lecturer Of The Department Of Internal Diseases No.1, Fergana Branch Of The Tashkent Medical Academy, Fergana City, The Republic Of Uzbekistan
tajmspr 2020
VOL. 2 / NO. 07 JULY
VOLUME 2
ISSUE 07
YEAR 2020
PAGES 38-42

Abstract

The aim of the work was to study the state of the prostacyclin-thromboxane system (PTS)
and platelet functions in patients with coronary heart disease (CHD). 86 patients with CHD
were examined. The state of PTS was examined by the content of prostacyclin and
thromboxane in the blood, determined by radioimmunological method. Platelet hemostasis
was studied by the aggregation properties of platelets and the platelet release reaction for
β-thromboglobulin determined by radio immunological method. In patients with IHD,
pronounced violations of the prostacyclin-thromboxane balance in the direction of the
predominance of thromboxane and an increase in the functional activity of platelets,
expressed in increased aggregation and platelet release reaction. In patients with IHD
with post infarction cardio sclerosis, the level of prostacyclin in the blood significantly
exceeds the level in patients without myocardial infarction. The content of prostacyclin and
thromboxane in the blood does not differ in patients with stable angina of functional
classes III and IY.

Keywords

prostacyclin-thromboxane system platelet aggregation,

Downloads

Download data is not yet available.

References

  1. Adaptation, stress and prevention. 2001. pp. 215-226.
  2. Alekseeva N. P., Makoeva L. D. Influence of exogenous prostaglandins on the
  3. cardiovascular system. // Medicine. 2005. pp. 96-99.
  4. Baluda V. P. the Role of PG, Tha2 and PGI2 in regulating the aggregation process and
  5. platelet release reaction in normal and pathological conditions. // Pathological physiology
  6. and experimental therapy. 2004. issue 4. pp. 80-85.
  7. Baluda V. P. Platelet-vascular link of the hemostasis system in patients with ischemic
  8. heart disease under conditions of emotional stress. // Dissertation ... candidate of medical
  9. Sciences. 1994.
  10. Biological active substances in General anesthesia and intensive care. // Himmelfarb G.
  11. N., Gerasimov N. M. Tashkent, Medicine, 2000, p. 192.
  12. Boroyan R. G. Cardiovascular effects of prostaglandins and data on the mechanisms of
  13. their action. // Dissertation ... doctor of medical Sciences. 2004
  14. Ismailov sh. I., Valdman A.V. the Role of prostacyclin and thromboxane in the
  15. cardiovascular system. // Cardiology. 2001. No. 3, p. 111-116.
  16. Сhelly J. E., Fricot A.M, Garoia A. Hemodinamics effects of prostaciclin infusion after
  17. coronary bypass surgery. // Clinlcal pharmacology of prostaciclin. Edltors P. G. Lewis , J.
  18. O.Grady, Raven press, 2006 , p. 209-214